Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XTC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $48,750
Award facts
- Contract value 100% obligated
- $48,749.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 for Stelara 90 mg/mL syringes with an ultimate completion date of October 3, 2025. This award, issued on September 12, 2025, carries no set-aside designation and represents a delivery order under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $500 million through November 2026. The product will be delivered to Park Ridge, Illinois, and is funded through the Defense Logistics Agency's Medical Supply Chain division to support pharmaceutical supply needs across Department of Defense healthcare facilities.
Stelara is a biologic immunosuppressant medication used to treat various autoimmune conditions, and this delivery order reflects DMS Pharmaceutical Group's established role as a critical supplier of specialty pharmaceutical products to federal military health systems. The company's contract portfolio demonstrates consistent success in securing federal pharmaceutical distribution awards across a broad range of products, including branded biologics, specialty injections, and oncology treatments. This delivery order is one of numerous similar awards the company has secured, underscoring its significant positioning within the federal pharmaceutical supply chain and its capacity to reliably deliver specialized medical products to Defense Department healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DX25F6XTC?
SPE2DX25F6XTC was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 12, 2025.
How much is contract SPE2DX25F6XTC worth?
The government has obligated $48,750 on SPE2DX25F6XTC.
Is contract SPE2DX25F6XTC an order under another contract?
Yes. SPE2DX25F6XTC is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTC competed?
The extent of competition for SPE2DX25F6XTC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award